Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer. - Bocobo A; Whitman J; Keenan BP; Koser KL; Kidder WA; Piawah S; Van Loon K; Behr SC; Kolli KP; Chen X; Onodera C; Pande M; et al. (Clinical colorectal cancer, 2026)